SNDX NASDAQ · Healthcare · FY 2025-12-31

Syndax Pharmaceuticals Inc

0.05.110.315.420.6ABVfair 0.74buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 19.05 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
19.050 USD
Market cap
1.67B USD
P / B
25.76
P / E
EPS
-3.290
DPS / yield
(0.0%)
NAV / share
0.739
Graham number
Z'' score
-7.27
Piotroski F
1 / 9
Beneish M
2.77
ROIC vs WACC
-83.2% vs 7.2%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.